| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PharmaTher Holdings Ltd (OTCQB: PHRRF)
PHRRF Technical Analysis
4
| As on 12th Nov 2024 PHRRF STOCK Price closed @ 0.16 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.14 & Strong Buy for SHORT-TERM with Stoploss of 0.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHRRFSTOCK Price
| Open | 0.16 | Change | Price | % |
| High | 0.16 | 1 Day | 0.00 | 0.00 |
| Low | 0.15 | 1 Week | 0.00 | 0.00 |
| Close | 0.16 | 1 Month | -0.02 | -11.11 |
| Volume | 192900 | 1 Year | 0.08 | 100.00 |
| 52 Week High 0.32 | 52 Week Low 0.06 | ||||
OTCQB USA Most Active Stocks
| BGLC | 0.55 | 96.43% |
| ABQQ | 0.00 | % |
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| EFSH | 0.29 | 16.00% |
| BMIX | 0.01 | % |
| FNMA | 3.44 | 4.88% |
| BTCWF | 0.10 | 150.00% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| PHRRF Daily Charts |
PHRRF Intraday Charts |
Whats New @ Bazaartrend |
PHRRF Free Analysis |
|
|
PHRRF Important Levels Intraday
| RESISTANCE | 0.18 |
| RESISTANCE | 0.17 |
| RESISTANCE | 0.17 |
| RESISTANCE | 0.17 |
| SUPPORT | 0.15 |
| SUPPORT | 0.15 |
| SUPPORT | 0.15 |
| SUPPORT | 0.14 |
PHRRF Forecast January 2025
| 4th UP Forecast | 0.41 |
| 3rd UP Forecast | 0.33 |
| 2nd UP Forecast | 0.28 |
| 1st UP Forecast | 0.23 |
| 1st DOWN Forecast | 0.09 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.09 |
PHRRF Weekly Forecast
| 4th UP Forecast | 0.18 |
| 3rd UP Forecast | 0.17 |
| 2nd UP Forecast | 0.17 |
| 1st UP Forecast | 0.17 |
| 1st DOWN Forecast | 0.15 |
| 2nd DOWN Forecast | 0.15 |
| 3rd DOWN Forecast | 0.15 |
| 4th DOWN Forecast | 0.14 |
PHRRF Forecast2025
| 4th UP Forecast | 0.66 |
| 3rd UP Forecast | 0.5 |
| 2nd UP Forecast | 0.4 |
| 1st UP Forecast | 0.3 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | -0.08 |
| 3rd DOWN Forecast | -0.18 |
| 4th DOWN Forecast | -0.34 |
PharmaTher Holdings Ltd ( OTCQB USA Symbol : PHRRF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PHRRF Business Profile
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's products in pipeline include Ketamine, which is in Phase I and II clinical trials for Parkinson's disease indications, as well as in preclinical trials for ALS-Lou Gehrig's disease indications; and KETABET, which is in Phase I and II clinical trials for mental health, neurological, and pain disorders. It is also developing microneedle patches for the delivery of antivirals for the treatment of influenza; and NCEs for multiple indications. The company is headquartered in Vancouver, Canada. Address: West Georgia Street, Vancouver, BC, Canada, V6E 4N7
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service